细胞外囊泡作为动脉样硬化心血管疾病中介的媒介
Lucia Zisser1,2, Christoph J Binder1
1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Journal of lipid and atherosclerosis
|October 2, 2024
概括
细胞外囊泡 (EVs) 是动脉样硬化的关键参与者,这是一种导致动脉斑块积累的疾病. 本综述探讨了电动汽车如何影响斑块发育,并强调了当前的研究挑战.
科学领域:
- 心血管生物学 心血管生物学
- 细胞生物学 细胞生物学
- 生物医学科学 生物医学科学
背景情况:
- 动脉样硬化是一种由脂蛋白积累和炎症驱动的慢性炎症性动脉疾病.
- 它导致斑块形成,可能导致心肌梗塞和缺血性中风.
- 细胞外囊泡 (EVs),细胞间通信的媒介,正在成为动脉样硬化研究的关键因素.
研究的目的:
- 审查EVs调节动脉生成的已知机制.
- 概述目前在动脉样硬化中研究EVs的局限性和挑战.
主要方法:
- 这是一篇综述性文章,综合了EV和动脉样硬化的现有研究.
- 它侧重于EV参与斑块形成的机制.
- 这篇评论讨论了不同的EV亚型,它们的起源和功能影响.
主要成果:
- 来自各种细胞类型的EV在斑块形成的各个阶段都起作用.
- 它们的功能作用取决于环境,受细胞起源和病理生理条件的影响.
- EVs有助于动脉样硬化特征的炎症过程和脂蛋白积累.
结论:
- 电动动脉是动脉样硬化病变的组成部分.
- 需要进一步的研究,以克服了解EV功能和治疗潜力的现有局限性.
- 准EV可能为治疗动脉样硬化及其并发症提供新的策略.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Inflammation
53.2K
Overview
53.2K
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Lipid-derived Compounds in the Human Body
4.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K


